Virtual Medicinal Product (VMP) - Tenofovir alafenamide 25mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Tenofovir alafenamide 25mg tablets | Start Date 20-12-2017 | End Date |
| Previous Name | Previous Name Tenofovir 25mg tablets | Start Date 05-12-2017 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J05AF13
- BNF Codes
-
- BNF code 05030301
| Code | Start Date | End Date |
|---|---|---|
| 34971911000001104 | 05-12-2017 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Tenofovir alafenamide fumarate | Based on Base Substance | Tenofovir alafenamide | 25 mg |
Name
Tenofovir alafenamide fumarate
Basis of strength description
Based on Base Substance
BOSS
Tenofovir alafenamide
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
Parent Products
-
VTMTenofovir alafenamide
-
VMP(Current) Tenofovir alafenamide 25mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 tablet |